The Applicability of the Cumberland Ankle Instability Tool in Basketball Athletes.
Launched by HACETTEPE UNIVERSITY · Apr 14, 2025
Trial Information
Current as of June 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is studying the Cumberland Ankle Instability Tool (CAIT) to see how well it works for basketball players who have had ankle injuries, like sprains. Ankle injuries are common in basketball, so understanding how to assess ankle stability is important for helping athletes recover and prevent future injuries. If the CAIT proves to be effective for basketball athletes, it could be used in future studies and treatments.
To participate in this trial, you need to be between 16 and 45 years old, have a history of ankle sprains, and currently train in basketball at least once a week. The trial is not yet recruiting participants, but if you qualify and decide to join, you can expect to help researchers learn more about ankle instability in basketball players. This information could lead to better care and support for athletes dealing with similar injuries.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Age between 16 and 45
- • History of ankle sprain
- • Participation in basketball training at least once per week
- Exclusion Criteria:
- • Participation in basketball training at least once per week
About Hacettepe University
Hacettepe University is a leading research institution in Turkey, renowned for its commitment to advancing medical science and healthcare through innovative clinical research. With a strong emphasis on interdisciplinary collaboration, the university supports a wide range of clinical trials aimed at improving patient outcomes and developing new therapeutic approaches. Hacettepe University is dedicated to maintaining the highest ethical standards and regulatory compliance in its research endeavors, fostering an environment that promotes scientific excellence and contributes to the global body of medical knowledge.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported